Publications by authors named "F Vescio"
Adipose tissue macrophages (ATMs) and mast cells (MCs) play a role in immune responses. More recently, their involvement in tumor angiogenesis and chronic inflammatory conditions in patients with obesity has been discovered. Furthermore, a higher BMI (Body Mass Index) value corresponds to a higher inflammatory state.
View Article and Find Full Text PDFIn this editorial, we focus specifically on the mechanisms by which pancreatic inflammation affects pancreatic cancer. Cancer of the pancreas remains one of the deadliest cancer types. The highest incidence and mortality rates of pancreatic cancer are found in developed countries.
View Article and Find Full Text PDFWhat are the true benefits of robotic pancreaticoduodenectomy for patients with pancreatic cancer?
Expert Rev Gastroenterol Hepatol
May 2024
Article Synopsis
- Pancreatic ductal adenocarcinoma (PDAC) treatment can improve survival rates with multimodal approaches, particularly through high-quality surgeries like pancreaticoduodenectomy (PD), which has advanced to include robotic-assisted procedures (RPD).
- A literature review compared RPD and open pancreaticoduodenectomy (OPD), assessing factors like surgery duration, blood loss, postoperative pain, complications, and oncological outcomes.
- Findings indicate that RPD has similar or longer operation times but better outcomes in blood loss, pain management, and some postoperative complications, with comparable or enhanced oncological results, suggesting RPD’s safer and potentially superior role in PD treatment as experience grows.
Background: The Coronavirus 2019 (COVID-19) pandemic has favored the growth of telemedicine systems and in this context the idea of Metaverse was born and developed. A 3D reality in which people can interact with each other through digital reproductions of themselves. Metaverse has already been tested in numerous medical fields due to its ability to combine visual and auditory information with tactile sensations.
View Article and Find Full Text PDFBackground: Consolidated information on the effectiveness of COVID-19 booster vaccination in Europe are scarce.
Research Design And Methods: We assessed the effectiveness of a booster dose of an mRNA vaccine against any SARS-CoV-2 infection (symptomatic or asymptomatic) and severe COVID-19 (hospitalization or death) after over two months from administration among priority target groups (n = 18,524,568) during predominant circulation of the Delta variant in Italy (July-December 2021).
Results: Vaccine effectiveness (VE) against SARS-CoV-2 infection and, to a lesser extent, against severe COVID-19, among people ≥60 years and other high-risk groups (i.